Crown Bioscience Is One of Several Life Science Companies Planning Taiwan IPO

Crown Bioscience International, an early-stage US-China CRO/CMO focused on cancer, recently applied for listing on the Mainboard of Taiwan's GreTai Securities Market. At the recent BioTaiwan conference, there was considerable "buzz" about listing in Taiwan, even if, like CrownBio, the biopharma companies aren't located there. Singapore's Aslan Pharma, for example, is said to be considering Taiwan for its upcoming IPO, and JHL Biotech, a high profile Taiwan-China biosimilar company formed by US-biotech veterans, listed in Taiwan last year.